| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f309eb5a45af5a5390be796b825cc78 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate |
2020-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d3ba7c411a03e1c8e1c425d751eb96f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd3112f95a8e489f753bf1aa0933606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f41b201398dd301b4d1fd5c163fe7d1 |
| publicationDate |
2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111135286-A |
| titleOfInvention |
Application of cilengitide in the preparation of medicines for preventing and treating radiation-induced lung injury |
| abstract |
The invention discloses the application of cilengitide in the preparation of medicines for preventing and treating radiation-induced lung injury; cilengitide can obviously improve the degree of fibrosis and the health state of lung tissue after irradiation, increase the overall survival time, and no lethality is observed. side effects, with good safety. |
| priorityDate |
2020-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |